PRENasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as PRENW
Prenetics Global Ltd
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 30, 2026
$19.02+0.50 (+2.70%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Prenetics Global's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
5 buys · 0 sales
Net bought $999.70K
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Danny Sheng Wu Yeung | Chief Executive Officer, Director | 1,682,207 | Aug 24, 2026 |
| Thuan Yen Tat | VP, Finance of IM8 (US) LLC | – | Sep 4, 2026 |
| Brian J. Rosin | CFO of IM8 (US) LLC | 23,100 | Aug 26, 2026 |
| Hoi Chun Lo | Chief Financial Officer | 566,013 | Aug 24, 2026 |
| Hudson Blake Leogrande | Director | 6,001 | Sep 4, 2026 |
| Caroline S. Levy | Director | – | Aug 26, 2026 |
| Yin Pan Cheng | Director | 59,051 | Jun 16, 2026 |
| David Vanderveen | Director | 46,897 | Jun 16, 2026 |
| Darshan Ravindra Shah | Director | 4,506 | Mar 30, 2026 |
| Capital Management Holdings Ltd M13 | – | – | Jun 16, 2026 |
| Yeung Ltd Da | – | – | Mar 30, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Hudson Blake Leogrande Director | Sep 4, 2026 | Option exercise | +2,000 | – | – | 6,001 |
| Brian J. Rosin CFO of IM8 (US) LLC | Aug 25, 2026 | Buy | +5,100 | $22.80 | $116.28K | 23,100 |
| Brian J. Rosin CFO of IM8 (US) LLC | Aug 24, 2026 | Buy | +18,000 | $21.19 | $381.42K | 18,000 |
| Danny Sheng Wu Yeung Chief Executive Officer, Director | Aug 24, 2026 | Buy | +6,000 | $20.90 | $125.40K | 101,235 |
| Danny Sheng Wu Yeung Chief Executive Officer, Director | Aug 24, 2026 | Buy | +11,181 | $21.40 | $239.27K | 112,416 |
| Hoi Chun Lo Chief Financial Officer | Aug 21, 2026 | Option exercise | +32,736 | – | – | 566,013 |
| Hoi Chun Lo Chief Financial Officer | Aug 21, 2026 | Option exercise | +45,815 | – | – | 566,013 |
| Danny Sheng Wu Yeung Chief Executive Officer, Director | Aug 20, 2026 | Other | −49,912 | – | – | 87,735 |
| Danny Sheng Wu Yeung Chief Executive Officer, Director | Aug 20, 2026 | Option exercise | +53,953 | – | – | 137,647 |
| Danny Sheng Wu Yeung Chief Executive Officer, Director | Aug 20, 2026 | Buy | +7,500 | $18.31 | $137.33K | 95,235 |
| Hudson Blake Leogrande Director | Aug 4, 2026 | Option exercise | +2,001 | – | – | 4,001 |
| Hudson Blake Leogrande Director | Jul 4, 2026 | Option exercise | +2,000 | – | – | 2,000 |
| Yin Pan Cheng Director | Jun 15, 2026 | Option exercise | +15,873 | – | – | 59,051 |
| David Vanderveen Director | Jun 15, 2026 | Option exercise | +6,944 | – | – | 45,249 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.